{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:02:46Z","timestamp":1793930566557,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Germline genetic susceptibilities of rare cancers of the esophagus, stomach, small intestine, testis, (nonmedullary) thyroid gland and bone with high familial risks are not well known. Here, we use familial risk data from the Swedish Family-Cancer Database which contains records of cancers in Swedish families obtained over a century. We compare familial risks for offspring diagnosed with any of these cancers when their parent had or had not that cancer. We review the global literature of the reported constitutional variants that may explain part of the familial risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main body<\/jats:title>\n            <jats:p>Familial risks for esophageal and stomach cancers are about 2.0 and apart from early-onset stomach cancer few high-risk variants are known. Genetic studies may be hampered by dominant environmental risk factors for these cancers. Small intestinal carcinoids have a very high familial risk (28 between siblings) but no high-risk genes have been identified to explain this. Low-risk polygenic variants have been identified. Small intestinal adenocarcinoma is a manifestation in Lynch syndrome. Testicular and thyroid cancers are characterized by high familial risk (about 5) which may be explained largely by a polygenic background, although thyroid cancer is a component in a number of rare cancer syndromes. Several predisposing genes have been identified for bone cancer (familial risk 7).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The discussed cancers are rare and they present with a relatively high familial risk, in spite of lacking identified high-penetrant constitutional variants. It is possible that the polygenic component, already recognized for testis cancer, is stronger than previously expected. Thus polygenic models with rare high\/moderate- and low-risk variants could fit the familial risk and shape the germline genetic landscape of these cancers. Polygenic background may have clinical implications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13053-024-00303-6","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:19:14Z","timestamp":1740644354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers"],"prefix":"10.1186","volume":"23","author":[{"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Koskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"2","key":"303_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007;11(2):103\u20135.","journal-title":"Cancer Cell"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919\u201332.","journal-title":"N Engl J Med"},{"key":"303_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers13174385","volume":"13","author":"K Hemminki","year":"2021","unstructured":"Hemminki K, Sundquist K, Sundquist J, F\u00f6rsti A, Hemminki A, Li X. Familial risks and proportions describing Population Landscape of Familial Cancer. Cancers. 2021;13:17.","journal-title":"Cancers"},{"issue":"4","key":"303_CR4","doi-asserted-by":"publisher","first-page":"e19085","DOI":"10.1371\/journal.pone.0019085","volume":"6","author":"Y Wang","year":"2011","unstructured":"Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. PLoS ONE. 2011;6(4):e19085.","journal-title":"PLoS ONE"},{"issue":"4","key":"303_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jncc.2022.09.004","volume":"2","author":"K Zou","year":"2022","unstructured":"Zou K, Sun P, Huang H, Zhuo H, Qie R, Xie Y, et al. Etiology of lung cancer: evidence from epidemiologic studies. J Natl Cancer Cent. 2022;2(4):216\u201325.","journal-title":"J Natl Cancer Cent"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","volume":"392","author":"H Zur Hausen","year":"2009","unstructured":"Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392:1\u201310.","journal-title":"Virology"},{"issue":"5","key":"303_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, Wahlstr\u00f6m C, et al. Breast Cancer Risk Genes - Association Analysis in more than 113,000 women. N Engl J Med. 2021;384(5):428\u201339.","journal-title":"N Engl J Med"},{"issue":"3","key":"303_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.gim.2021.11.009","volume":"24","author":"E Hassanin","year":"2022","unstructured":"Hassanin E, May P, Aldisi R, Spier I, Forstner AJ, N\u00f6then MM, et al. Breast and prostate cancer risk: the interplay of polygenic risk, rare pathogenic germline variants, and family history. Genet Med. 2022;24(3):576\u201385.","journal-title":"Genet Med"},{"issue":"1","key":"303_CR9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s42003-024-06995-9","volume":"7","author":"JH Kang","year":"2024","unstructured":"Kang JH, Lee Y, Kim DJ, Kim JW, Cheon MJ, Lee BC. Polygenic risk and rare variant gene clustering enhance cancer risk stratification for breast and prostate cancers. Commun Biology. 2024;7(1):1289.","journal-title":"Commun Biology"},{"key":"303_CR10","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/ijc.24795","volume":"126","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2010;126:2259\u201367.","journal-title":"Int J Cancer"},{"key":"303_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.27462","volume":"131","author":"J Ji","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer. 2012;131:2085\u201393.","journal-title":"Int J Cancer"},{"issue":"11","key":"303_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrc.2017.82","volume":"17","author":"A Sud","year":"2017","unstructured":"Sud A, Kinnersley B, Houlston RS. Genome-wide association studies of cancer: current insights and future perspectives. Nat Rev Cancer. 2017;17(11):692\u2013704.","journal-title":"Nat Rev Cancer"},{"key":"303_CR13","doi-asserted-by":"crossref","unstructured":"Jeremiasen M, Linder G, Hedberg J, Lundell L, Bj\u00f6r O, Lindblad M et al. Improvements in esophageal and gastric cancer care in Sweden-population-based results 2007\u20132016 from a national quality register. Dis Esophagus. 2020;33(3).","DOI":"10.1093\/dote\/doz070"},{"issue":"4","key":"303_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3322\/caac.21185","volume":"63","author":"J Lagergren","year":"2013","unstructured":"Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63(4):232\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"303_CR15","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1007\/s10620-022-07387-x","volume":"67","author":"PLS Uson Jr","year":"2022","unstructured":"Uson PLS Jr., Kunze KL, Golafshar MA, Botrus G, Riegert-Johnson D, Boardman L, et al. Germline Cancer testing in unselected patients with gastric and esophageal cancers: a multi-center prospective study. Dig Dis Sci. 2022;67(11):5107\u201315.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"303_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1053\/j.gastro.2023.07.015","volume":"165","author":"M Lee","year":"2023","unstructured":"Lee M, Eng G, Handte-Reinecker A, Deshpande VS, Yilmaz OH, Gala MK. Germline determinants of esophageal adenocarcinoma. Gastroenterology. 2023;165(5):1276\u2013e97.","journal-title":"Gastroenterology"},{"issue":"5","key":"303_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2023.01.038","volume":"164","author":"L Decourtye-Espiard","year":"2023","unstructured":"Decourtye-Espiard L, Guilford P. Hereditary diffuse gastric Cancer. Gastroenterology. 2023;164(5):719\u201335.","journal-title":"Gastroenterology"},{"issue":"10251","key":"303_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"key":"303_CR19","doi-asserted-by":"crossref","unstructured":"Landerholm K. Time trends in incidence and survival of small intestinal cancer in Sweden. BJS Open. 2021;5(1).","DOI":"10.1093\/bjsopen\/zraa044"},{"issue":"8","key":"303_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cgh.2013.02.025","volume":"11","author":"E Kharazmi","year":"2013","unstructured":"Kharazmi E, Pukkala E, Sundquist K, Hemminki K. Familial risk of small intestinal carcinoid and adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11(8):944\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"303_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2020","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT, Ten Broeke SW, Plazzer JP, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective Lynch Syndrome Database. Genet Med. 2020;22(1):15\u201325.","journal-title":"Genet Med"},{"issue":"1","key":"303_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2015.04.008","volume":"149","author":"Y Sei","year":"2015","unstructured":"Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, et al. A Hereditary Form of Small Intestinal Carcinoid Associated with a germline mutation in Inositol Polyphosphate Multikinase. Gastroenterology. 2015;149(1):67\u201378.","journal-title":"Gastroenterology"},{"issue":"1","key":"303_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.dld.2016.10.007","volume":"49","author":"L de Mestier","year":"2017","unstructured":"de Mestier L, Pasmant E, Fleury C, Brixi H, Sohier P, F\u00e9ron T, et al. Familial small-intestine carcinoids: chromosomal alterations and germline inositol polyphosphate multikinase sequencing. Dig Liver Dis. 2017;49(1):98\u2013102.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"303_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/ERC-17-0196","volume":"24","author":"JP Dumanski","year":"2017","unstructured":"Dumanski JP, Rasi C, Bj\u00f6rklund P, Davies H, Ali AS, Gr\u00f6nberg M, et al. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors. Endocr Relat Cancer. 2017;24(8):427\u201343.","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"303_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ng.394","volume":"41","author":"EA Rapley","year":"2009","unstructured":"Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41(7):807\u201310.","journal-title":"Nat Genet"},{"issue":"1","key":"303_CR26","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41467-021-24334-y","volume":"12","author":"J Pluta","year":"2021","unstructured":"Pluta J, Pyle LC, Nead KT, Wilf R, Li M, Mitra N, et al. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat Commun. 2021;12(1):4487.","journal-title":"Nat Commun"},{"issue":"1","key":"303_CR27","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1038\/s41467-020-16483-3","volume":"11","author":"YD Zhang","year":"2020","unstructured":"Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020;11(1):3353.","journal-title":"Nat Commun"},{"issue":"3","key":"303_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.eururo.2018.05.036","volume":"74","author":"C Loveday","year":"2018","unstructured":"Loveday C, Law P, Litchfield K, Levy M, Holroyd A, Broderick P, et al. Large-scale analysis demonstrates familial testicular Cancer to have Polygenic Aetiology. Eur Urol. 2018;74(3):248\u201352.","journal-title":"Eur Urol"},{"issue":"6","key":"303_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jmedgenet-2012-101412","volume":"50","author":"M Fallah","year":"2013","unstructured":"Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five nordic countries. J Med Genet. 2013;50(6):373\u201382.","journal-title":"J Med Genet"},{"issue":"1","key":"303_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13053-022-00215-3","volume":"20","author":"T Kamani","year":"2022","unstructured":"Kamani T, Charkhchi P, Zahedi A, Akbari MR. Genetic susceptibility to hereditary non-medullary thyroid cancer. Hereditary cancer Clin Pract. 2022;20(1):9.","journal-title":"Hereditary cancer Clin Pract"},{"key":"303_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/CLEP.S467874","volume":"16","author":"F Zitricky","year":"2024","unstructured":"Zitricky F, Koskinen A, Sundquist K, Sundquist J, Liska V, F\u00f6rsti A, et al. Survival in thyroid Cancer in Sweden from 1999 to 2018. Clin Epidemiol. 2024;16:659\u201371.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"303_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41379-021-00905-8","volume":"35","author":"IA Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez IA, Stewart DR, Schultz KAP, Field AP, Hill DA, Dehner LP. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathology: Official J United States Can Acad Pathol Inc. 2022;35(1):4\u201322.","journal-title":"Mod Pathology: Official J United States Can Acad Pathol Inc"},{"key":"303_CR33","doi-asserted-by":"crossref","unstructured":"Tichanek F, F\u00f6rsti A, Hemminki O, Hemminki A, Hemminki K. Steady survival improvements in soft tissue and bone sarcoma in the nordic countries through 50 years. Cancer Epidemiol. 2023:102449.","DOI":"10.1016\/j.canep.2023.102449"},{"issue":"1","key":"303_CR34","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-020-16067-1","volume":"11","author":"S Akhavanfard","year":"2020","unstructured":"Akhavanfard S, Padmanabhan R, Yehia L, Cheng F, Eng C. Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. Nat Commun. 2020;11(1):2206.","journal-title":"Nat Commun"},{"issue":"24","key":"303_CR35","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1001\/jama.2020.21360","volume":"324","author":"J Maret-Ouda","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020;324(24):2536\u201347.","journal-title":"JAMA"},{"issue":"1","key":"303_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12920-023-01469-z","volume":"16","author":"E Hassanin","year":"2023","unstructured":"Hassanin E, Spier I, Bobbili DR, Aldisi R, Klinkhammer H, David F, et al. Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence. BMC Med Genom. 2023;16(1):42.","journal-title":"BMC Med Genom"},{"issue":"6","key":"303_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/1055-9965.EPI-23-1432","volume":"33","author":"JA Collister","year":"2024","unstructured":"Collister JA, Liu X, Littlejohns TJ, Cuzick J, Clifton L, Hunter DJ. Assessing the value of incorporating a polygenic risk score with nongenetic factors for Predicting breast Cancer diagnosis in the UK Biobank. Cancer Epidemiol Biomarkers Prev. 2024;33(6):812\u201320.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"303_CR38","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1200\/JCO.23.00295","volume":"42","author":"N Mars","year":"2024","unstructured":"Mars N, Kerminen S, Tamlander M, Pirinen M, Jakkula E, Aaltonen K, et al. Comprehensive inherited risk estimation for risk-based breast Cancer screening in women. J Clin Oncol. 2024;42(13):1477\u201387.","journal-title":"J Clin Oncol"},{"issue":"12","key":"303_CR39","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajhg.2022.10.009","volume":"109","author":"N Mars","year":"2022","unstructured":"Mars N, Lindbohm JV, Della Briotta Parolo P, Wid\u00e9n E, Kaprio J, Palotie A, et al. Systematic comparison of family history and polygenic risk across 24 common diseases. Am J Hum Genet. 2022;109(12):2152\u201362.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"303_CR40","doi-asserted-by":"publisher","first-page":"e003262","DOI":"10.1161\/CIRCGEN.120.003262","volume":"14","author":"NJ Reid","year":"2021","unstructured":"Reid NJ, Brockman DG, Elisabeth Leonard C, Pelletier R, Khera AV. Concordance of a high polygenic score among relatives: implications for genetic Counseling and Cascade Screening. Circ Genom Precis Med. 2021;14(2):e003262.","journal-title":"Circ Genom Precis Med"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-024-00303-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13053-024-00303-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-024-00303-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:19:18Z","timestamp":1740644358000},"score":1,"resource":{"primary":{"URL":"https:\/\/hccpjournal.biomedcentral.com\/articles\/10.1186\/s13053-024-00303-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s13053-024-00303-6","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not relevant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Own data were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data were obtained from the literature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"A. H. is shareholder in Circio Holdings ASA and employee and shareholder in TILT Biotherapeutics Ltd. Other authors declared no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}